Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788527 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
A NA study, sponsored by Mount Sinai Hospital, Canada.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01788527 is a NA study that has completed, run by Mount Sinai Hospital, Canada. The registered enrollment target is 325 participants.
The verdict
NCT01788527, a NA study, has completed, sponsored by Mount Sinai Hospital, Canada.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.
Interventions
- DEVICE CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01788527
The ClinicalTrials.gov registry entry for NCT01788527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mount Sinai Hospital, Canada, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.
NCT01788527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01788527 about?
NCT01788527 is a clinical study titled "Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial". The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.
What is the current status of trial NCT01788527?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2013-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01788527?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT01788527?
This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.